Large daily doses of vitamin E, long touted as a virtual wonder drug that could protect against cancer, heart disease, dementia and other ailments, increase the risk for prostate cancer among middle-aged men, according to a large federal study released Tuesday. The analysis of data from more than 35,000 healthy men concluded that those who took vitamin E every day at the relatively large dose levels commonly sold in drug, grocery and health food stores were 17 percent more likely to develop prostate cancer. Read full article >>
Vitamin E Boosts Prostate Cancer Risk, Study Finds
Rob Stein, Washington Post
Tue, 10/11/2011 - 1:10pm
Sections: living
RELATED ARTICLES
- Study Finds Expanded Medicaid Increases Health Care Use
Come January, millions of low-income adults will gain health insurance coverage through Medicaid in one of the farthest-reaching provisions of the Obama health care law. More - New study: debt limit deadline likely extended
The likely deadline for Congress to prevent the government's first default will be later than earlier thought, a Washington think tank has found. The Bipartisan Policy Center said Friday that the government probably won't reach the brink of default until early September or early October. More - Cancer Physicians Attack High Drug Costs
More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More - Study: New bird flu jumped directly from chickens
Chinese scientists have for the first time found strong evidence of how humans got infected with a new strain of bird flu: from chickens at a live market. In a small study of four patients who caught the new H7N9 virus, Chinese scientists compared swabs from birds at live markets in eastern China to virus samples from patients. More - Patients’ Genes Seen as Future of Cancer Care
Major academic medical centers in New York and around the country are spending and recruiting heavily in what has become an arms race within the war on cancer. The investments are based on the belief that the medical establishment is moving toward the routine sequencing of every patient’s genome in the quest for “precision medicine,” a course for prevention and treatment based on the special, even unique characteristics of the patient’s genes. More
BING NEWS:
- Testosterone Therapy May Not Up Prostate Cancer Recurrence Risk
Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.
01/10/2025 - 1:19 am | View Link - PSMA-PET Provides Additional Risk Stratification in High-Risk Prostate Cancer
Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate-specific membrane antigen-positron emission tomography (PSMA-PET) results were ...
01/9/2025 - 5:30 pm | View Link - Can Financial Incentives Boost Active Surveillance Rates for Low-Risk Prostate Cancer?
A cohort study analyzed data from 15,273 men with prostate cancer to determine active surveillance rates at difference points in time.
01/8/2025 - 6:57 pm | View Link - Study identifies genes linked to high prostate cancer mortality rates
Researchers shed light on the genes that could be linked to the high mortality rates of prostate cancer among men of African descent.
01/5/2025 - 11:00 am | View Link - Advanced imaging technology detects undiagnosed metastases in high-risk prostate cancer
A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...
01/3/2025 - 4:16 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more